Avanos Medical
AVNS
257 hedge funds and large institutions have $842M invested in Avanos Medical in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 64 increasing their positions, 79 reducing their positions, and 38 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $865M → $842M (-$22.5M)
3% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 38
1% less funds holding
Funds holding: 260 → 257 (-3)
1.87% less ownership
Funds ownership: 94.02% → 92.15% (-1.9%)
19% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 79
78% less call options, than puts
Call options by funds: $49K | Put options by funds: $224K
Top Buyers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$5.67M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$5.35M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.46M |
| 4 |
PIM
Paradice Investment Management
Denver,
Colorado
|
+$1.35M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$1.22M |
Top Sellers
| 1 |
BlackRock
New York
|
-$4.83M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$3.17M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.95M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.61M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.51M |
AVNS Hedge Fund Activity: Q2 2024 in Review
257 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2024, worth a combined $842M — down 2.6% from $865M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of AVNS and 37 opened new positions — a net loss of 1 holder — while 79 trimmed existing stakes and 64 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $5.67M. The largest seller was BlackRock, cutting an estimated $4.83M.
- 257 institutional investors held Avanos Medical (AVNS) as of Q2 2024, down from 260 in Q1 2024.
- Funds reported $842M of Avanos Medical stock for Q2 2024, down 2.6% quarter-over-quarter.
- 37 funds opened new Avanos Medical positions in Q2 2024 and 38 closed out, a net change of -1 holder.
- The largest Avanos Medical buyer in Q2 2024 was T. Rowe Price Investment Management, an estimated $5.67M added.
- The largest Avanos Medical seller in Q2 2024 was BlackRock, an estimated $4.83M sold.
Based on aggregated 13F filings for Q2 2024.